Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00083148 · ClinicalTrials.gov registry record · Phase 1

Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

A Phase 1 study of Breast Cancer, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
Phase 1
Development phase
12
Enrollment target
1
Study location

NCT00083148 is a Phase 1 study of Breast Cancer that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 12 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00083148, a Phase 1 study of Breast Cancer, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy, such as irinotecan and capecitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may help capecitabine kill more tumor cells by making tumor cells more sensitive to the drug. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan and capecitabine in treating women with advanced breast cancer.

Conditions Studied

Breast Cancer

Interventions

  • DRUG capecitabine
  • DRUG irinotecan hydrochloride

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2002-11
Est. Completion 2006-09
Phase Phase 1

Sponsor

Roswell Park Cancer Institute

365 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00083148

The ClinicalTrials.gov registry entry for NCT00083148 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (100% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which capecitabine is the first listed.

NCT00083148 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00083148 about?

NCT00083148 is a clinical study titled "Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer". RATIONALE: Drugs used in chemotherapy, such as irinotecan and capecitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may help capecitabine kill more tumor cells by making tumor cells more sensitive to the drug. PURPOSE: This phase I trial is s...

What is the current status of trial NCT00083148?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2002-11. Estimated completion is 2006-09.

What conditions does trial NCT00083148 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00083148?

The interventions under investigation include: capecitabine (DRUG), irinotecan hydrochloride (DRUG).

Who is sponsoring clinical trial NCT00083148?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00083148 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.